Literature DB >> 11401144

Angiotensin-converting enzyme inhibition enhances a subthreshold stimulus to elicit delayed preconditioning in pig myocardium.

M T Jaberansari1, G F Baxter, C A Muller, S E Latouf, E Röth, L H Opie, D M Yellon.   

Abstract

OBJECTIVES: We assessed the effect of angiotensin-converting enzyme (ACE) inhibition in combination with a subthreshold preconditioning (PC) stimulus to elicit delayed preconditioning against infarction in pig myocardium.
BACKGROUND: Bradykinin triggers early PC. Angiotensin-converting enzyme inhibitors increase local bradykinin levels via inhibition of kinin breakdown and have been shown in experimental studies to augment early protection afforded by PC. A role for bradykinin in eliciting delayed PC has not so far been identified.
METHODS: We used a two-day protocol. On day 1 (closed chest), pigs were either sham-operated (group 1) or preconditioned, using balloon catheter inflation of the left anterior descending (LAD) coronary artery, with either a full (4 x 5 min PC, group 2) or subthreshold PC stimulus (2 x 2 min PC, group 3). Additional groups were pre-treated with perindoprilat (0.06 mg/kg i.v.) before sham (group 4) or subthreshold PC (group 5). On day 2 (open chest), all pigs were subjected to 40 min occlusion of the LAD followed by 3 h of reperfusion. Infarct size was determined by tetrazolium staining.
RESULTS: Group 1 had a mean infarct size of 42.8+/-3.2% of the risk zone. Preconditioning with 4 x 5 min reduced the infarct size to 19.5+/-3.9% (p < 0.05). Groups 3 and 4 had infarct sizes not statistically different from group 1. However, combining perindoprilat with subthreshold PC resulted in a significant limitation of the infarction (18.4+/-3.1% p < 0.05), comparable with group 2.
CONCLUSIONS: This is the first study to show that ACE inhibition can augment a mild ischemic stimulus to induce a protected state 24 h later.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11401144     DOI: 10.1016/s0735-1097(01)01232-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  7 in total

Review 1.  Role of bradykinin in preconditioning and protection of the ischaemic myocardium.

Authors:  G F Baxter; Z Ebrahim
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

2.  Cardioprotection and ageing.

Authors:  Yon Hee Shim
Journal:  Korean J Anesthesiol       Date:  2010-03-30

3.  Apoptosis after reperfused myocardial infarction: Role of angiotensin II.

Authors:  Bodh I Jugdutt
Journal:  Exp Clin Cardiol       Date:  2004

4.  Bradykinin and angiotensin-converting enzyme inhibition in cardioprotection.

Authors:  G Jancso; Mt Jaberansari; B Gasz; Z Szanto; B Cserepes; E Röth
Journal:  Exp Clin Cardiol       Date:  2004

Review 5.  Redox signalling and cardioprotection: translatability and mechanism.

Authors:  P Pagliaro; C Penna
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

Review 6.  Myocardial protection in man--from research concept to clinical practice.

Authors:  Dennis V Cokkinos; Costas Pantos
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

7.  Angiotensin-converting enzyme inhibition and food restriction restore delayed preconditioning in diabetic mice.

Authors:  Gerry Van der Mieren; Ines Nevelsteen; Annelies Vanderper; Wouter Oosterlinck; Willem Flameng; Paul Herijgers
Journal:  Cardiovasc Diabetol       Date:  2013-02-23       Impact factor: 9.951

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.